z-logo
open-access-imgOpen Access
Reply to Walker et al
Author(s) -
Seth T. Walk,
Dejan Micić,
Andrzej T. Gałecki,
Mary A.M. Rogers,
Laraine Washer,
David W. Newton,
Preeti Malani,
Vincent B. Young,
David M. Aronoff
Publication year - 2013
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cit099
Subject(s) - clostridium difficile , covariate , medicine , biology , statistics , microbiology and biotechnology , antibiotics , mathematics
To the Editor—We thank Walker et al for their interest in our work [1]. Our study found no evidence of difference in clinical severity of Clostridium difficile infection (CDI) between patients infected with ribotype 027/078 strains compared with others, when adjusted for other covariates [2]. Adjustment for factors on the hypothesized causal pathway between exposure (ribotype) and outcome (severity), such as leukocyte count, has been addressed elsewhere [3]. Removing the leukocyte count as a covariate or including it in the definition of severe disease did not alter our findings [3].

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom